Menadione-induced apoptosis in U937 cells involves Bid cleavage and stefin B degradation

J Cell Biochem. 2019 Jun;120(6):10662-10669. doi: 10.1002/jcb.28356. Epub 2019 Jan 16.

Abstract

Earlier studies showed that the oxidant menadione (MD) induces apoptosis in certain cells and also has anticancer effects. Most of these studies emphasized the role of the mitochondria in this process. However, the engagement of other organelles is less known. Particularly, the role of lysosomes and their proteolytic system, which participates in apoptotic cell death, is still unclear. The aim of this study was to investigate the role of lysosomal cathepsins on molecular signaling in MD-induced apoptosis in U937 cells. MD treatment induced translocation of cysteine cathepsins B, C, and S, and aspartic cathepsin D. Once in the cytosol, some cathepsins cleaved the proapoptotic molecule, Bid, in a process that was completely prevented by E64d, a general inhibitor of cysteine cathepsins, and partially prevented by the pancaspase inhibitor, z-VAD-fmk. Upon loss of the mitochondrial membrane potential, apoptosome activation led to caspase-9 processing, activation of caspase-3-like caspases, and poly (ADP-ribose) polymerase cleavage. Notably, the endogenous protein inhibitor, stefin B, was degraded by cathepsin D and caspases. This process was prevented by z-VAD-fmk, and partially by pepstatin A-penetratin. These findings suggest that the cleaved Bid protein acts as an amplifier of apoptotic signaling through mitochondria, thus enhancing the activity of cysteine cathepsins following stefin B degradation.

Keywords: Bid; apoptosis; caspases; cathepsin D; cysteine cathepsins; menadione; stefin B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Apoptosomes / drug effects
  • Apoptosomes / metabolism
  • BH3 Interacting Domain Death Agonist Protein / genetics*
  • BH3 Interacting Domain Death Agonist Protein / metabolism
  • Caspase 3 / genetics
  • Caspase 3 / metabolism
  • Caspase 9 / genetics
  • Caspase 9 / metabolism
  • Cathepsin B / antagonists & inhibitors
  • Cathepsin B / genetics
  • Cathepsin B / metabolism
  • Cathepsin C / antagonists & inhibitors
  • Cathepsin C / genetics
  • Cathepsin C / metabolism
  • Cathepsin D / antagonists & inhibitors
  • Cathepsin D / genetics
  • Cathepsin D / metabolism
  • Cathepsins / antagonists & inhibitors
  • Cathepsins / genetics
  • Cathepsins / metabolism
  • Cystatin B / genetics*
  • Cystatin B / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Leucine / analogs & derivatives
  • Leucine / pharmacology
  • Lysosomes / drug effects*
  • Lysosomes / metabolism
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Pepstatins / pharmacology
  • Poly(ADP-ribose) Polymerases / genetics
  • Poly(ADP-ribose) Polymerases / metabolism
  • Protease Inhibitors / pharmacology
  • Proteolysis / drug effects
  • Signal Transduction
  • U937 Cells
  • Vitamin K 3 / pharmacology*

Substances

  • Amino Acid Chloromethyl Ketones
  • Antineoplastic Agents
  • Apoptosomes
  • BH3 Interacting Domain Death Agonist Protein
  • BID protein, human
  • CSTB protein, human
  • Pepstatins
  • Protease Inhibitors
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Vitamin K 3
  • Cystatin B
  • Poly(ADP-ribose) Polymerases
  • Cathepsins
  • CTSC protein, human
  • Cathepsin C
  • CASP3 protein, human
  • CASP9 protein, human
  • Caspase 3
  • Caspase 9
  • CTSB protein, human
  • Cathepsin B
  • cathepsin S
  • CTSD protein, human
  • Cathepsin D
  • Leucine
  • aloxistatin
  • pepstatin